U.S. Supreme Court Dissolves Injunction of CMS Vaccine Rule

Burr & Forman
Contact

Burr & Forman

On January 13, 2022, the United States Supreme Court, in a 5 to 4 vote, granted the government’s request to overturn the injunction on The Centers for Medicare and Medicaid (CMS) interim final rule requiring vaccinations of employees at certain Medicare and Medicaid-certified facilities. Federal courts had enjoined the rule in 26 states, while the remaining states were subject to enforcement as of January 27, 2022. CMS issued guidance on the Interim Final Rule (IFR) on December 28, 2021, mandating the vaccine in health care settings in those states not covered by the injunction.

As a result of the Court’s ruling, Medicare and Medicaid-certified facilities must comply with the vaccine mandate. CMS issued another QSO memo setting forth deadlines for Alabama, Alaska, Arizona, Arkansas, Georgia, Idaho, Indiana, Iowa, Kansas, Kentucky, Louisiana, Mississippi, Missouri, Montana, Nebraska, New Hampshire, North Dakota, Ohio, Oklahoma, South Carolina, South Dakota, Utah, West Virginia and Wyoming. The current deadlines outlined in the CMS guidance requires compliance with Phase 1 of having received at least one dose of a COVID-19 vaccine by Monday, February 14, 2022, and completion of a primary vaccine series (one shot of a single dose vaccine or last shot of a multi-dose vaccine) by March 15, 2022. The federal courts of appeal will now take up the matter on the merits but enforcement is not stayed in the meantime.

The guidance on enforcing the CMS vaccine mandate can be found here and here.

[View source.]

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Burr & Forman | Attorney Advertising

Written by:

Burr & Forman
Contact
more
less

Burr & Forman on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide